Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

20 Pathways to BuyoutLand$$$$

Working on 7 ADF opiods concurrently

1.) First ever generic ER 2 bead ADF labeled Oxycodone ELI-201
2.) First ever generic Embeda®
3.) First ever generic Troxyca® waiting on comparator product
4.) A $50 million dollar ANDA
5.) Approval/Launch of First ever one bead Abuse Deterrent generic (reformulated OxyContin® ) filed 09-20/2017
6.) File Huge Blockbuster Undisclosed NDA
7.) Lauch All four SunGen generics ($3 Billion combined markets)
8.) Buyout/Acquisition
9.)BP Partnership for entire ADF line
10.)Uplisting to NASDAQ exchange 2018-19
11.) First ever ER opiod with out food restrictions
12.) Complete PH III trials for the first ever 24 hour
13.) Generic of Reformulated Opana ® ER
14.) First ADF opiod for Chinese Pain Market by PuraCap/Humanwell
15.) Canadian Approval of SequestOx ® - patents in place
16.) FDA accepts citizen petition urging the FDA to phase out oral prescription opioid analgesics that lack abuse-deterrent properties
17.) First ever Immediate Release ADF labeled opiod with ORAL AD Labeling on hold till FDA guidance received
18.) Launch an additional 4 SunGen generics
19.) Chinese approval of SequestOx ®
20.) European approval of AD oxycodone/opiod - patents in place

ELTP